Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |